ECSP099599A - Procedimientos para la preparación de compuestos de urea sustituidos con piperidinilo - Google Patents
Procedimientos para la preparación de compuestos de urea sustituidos con piperidiniloInfo
- Publication number
- ECSP099599A ECSP099599A EC2009009599A ECSP099599A ECSP099599A EC SP099599 A ECSP099599 A EC SP099599A EC 2009009599 A EC2009009599 A EC 2009009599A EC SP099599 A ECSP099599 A EC SP099599A EC SP099599 A ECSP099599 A EC SP099599A
- Authority
- EC
- Ecuador
- Prior art keywords
- piperidinyl
- procedures
- preparation
- urea compounds
- compounds replaced
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- -1 PIPERIDINYL Chemical group 0.000 title 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 2
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 150000003672 ureas Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Se describen procedimientos para la síntesis de compuestos de urea sustituidos con piperidinilo. Esta invención también se refiere a intermediarios novedosos preparados durante esta síntesis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88711407P | 2007-01-29 | 2007-01-29 | |
| US97217707P | 2007-09-13 | 2007-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP099599A true ECSP099599A (es) | 2009-09-29 |
Family
ID=39493517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2009009599A ECSP099599A (es) | 2007-01-29 | 2009-08-27 | Procedimientos para la preparación de compuestos de urea sustituidos con piperidinilo |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20080207908A1 (es) |
| EP (1) | EP2125729A1 (es) |
| JP (1) | JP2010516785A (es) |
| KR (1) | KR20090107045A (es) |
| CN (1) | CN101663273A (es) |
| AR (1) | AR065079A1 (es) |
| AU (1) | AU2008210723A1 (es) |
| BR (1) | BRPI0807125A2 (es) |
| CA (1) | CA2675448A1 (es) |
| EA (1) | EA200901063A1 (es) |
| EC (1) | ECSP099599A (es) |
| IL (1) | IL199654A0 (es) |
| MX (1) | MX2009008093A (es) |
| TW (1) | TW200838851A (es) |
| WO (1) | WO2008094862A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090197916A1 (en) * | 2007-01-29 | 2009-08-06 | Arete Therapeutics, Inc | Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9216298D0 (en) * | 1991-08-15 | 1992-09-16 | Ici Plc | Piperidine derivatives |
| US7081454B2 (en) * | 2001-03-28 | 2006-07-25 | Bristol-Myers Squibb Co. | Tyrosine kinase inhibitors |
| ATE400272T1 (de) * | 2003-08-01 | 2008-07-15 | Chugai Pharmaceutical Co Ltd | Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer |
| TW200808723A (en) * | 2006-03-13 | 2008-02-16 | Univ California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
-
2008
- 2008-01-28 MX MX2009008093A patent/MX2009008093A/es not_active Application Discontinuation
- 2008-01-28 US US12/021,090 patent/US20080207908A1/en not_active Abandoned
- 2008-01-28 EP EP08728391A patent/EP2125729A1/en not_active Withdrawn
- 2008-01-28 JP JP2009547453A patent/JP2010516785A/ja not_active Withdrawn
- 2008-01-28 CN CN200880003369A patent/CN101663273A/zh active Pending
- 2008-01-28 BR BRPI0807125-0A2A patent/BRPI0807125A2/pt not_active IP Right Cessation
- 2008-01-28 KR KR1020097015884A patent/KR20090107045A/ko not_active Application Discontinuation
- 2008-01-28 WO PCT/US2008/052196 patent/WO2008094862A1/en active Application Filing
- 2008-01-28 TW TW097103103A patent/TW200838851A/zh unknown
- 2008-01-28 AU AU2008210723A patent/AU2008210723A1/en not_active Abandoned
- 2008-01-28 EA EA200901063A patent/EA200901063A1/ru unknown
- 2008-01-28 CA CA002675448A patent/CA2675448A1/en not_active Abandoned
- 2008-01-29 AR ARP080100360A patent/AR065079A1/es unknown
-
2009
- 2009-07-02 IL IL199654A patent/IL199654A0/en unknown
- 2009-08-27 EC EC2009009599A patent/ECSP099599A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010516785A (ja) | 2010-05-20 |
| CN101663273A (zh) | 2010-03-03 |
| AU2008210723A1 (en) | 2008-08-07 |
| IL199654A0 (en) | 2010-04-15 |
| EP2125729A1 (en) | 2009-12-02 |
| KR20090107045A (ko) | 2009-10-12 |
| CA2675448A1 (en) | 2008-08-07 |
| EA200901063A1 (ru) | 2009-12-30 |
| BRPI0807125A2 (pt) | 2014-04-08 |
| MX2009008093A (es) | 2009-08-12 |
| US20080207908A1 (en) | 2008-08-28 |
| WO2008094862A1 (en) | 2008-08-07 |
| TW200838851A (en) | 2008-10-01 |
| AR065079A1 (es) | 2009-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200702464A1 (ru) | Способы получения фенольных 4-бифенилилазетидин-2-онов | |
| ITMI20052486A1 (it) | Procedimento di sintesi di intermedi per la preparazione di astaxantina | |
| BRPI0520870B8 (pt) | compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila | |
| UY32292A (es) | Agonistas de s1p1 y métodos de preparación y uso | |
| CO6852084A2 (es) | Nuevos compuestos sustituidos con halógeno | |
| DK2114886T3 (da) | Fremgangsmåde til fremstilling af visse substituerede sulfiliminer | |
| CR20120295A (es) | Triazolopiridinas | |
| UA107791C2 (en) | Pesticidal compositions | |
| SV2010003617A (es) | Fungicidas | |
| CR11742A (es) | Derivados de arilsulfonil pirazolin carboxamidina como antagonistas de 5-ht6 | |
| BRPI0811035A2 (pt) | Composições de fibrina contendo compostos de estrôncio | |
| DK2889043T3 (da) | Syntetiske mellemprodukter til fremstilling af oligosaccharid-protein-konjugater | |
| AR058253A1 (es) | Procedimiento para la preparacion de ferri-succinilcaseina | |
| EA201101675A1 (ru) | Спироэпоксиды как промежуточные продукты синтеза | |
| EA201270256A1 (ru) | Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида | |
| ECSP088383A (es) | Tetrahidroquinolinas, su síntesis e intermediarios campo de la invención | |
| ECSP088151A (es) | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas | |
| ECSP088251A (es) | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas | |
| HK1124842A1 (en) | Methods of preparing imidazole-based compounds | |
| MA32834B1 (fr) | 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines | |
| HN2010001233A (es) | Uso derivados de acido tetramico para controlar nematodos | |
| PA8796801A1 (es) | Sintesis quiral de diazepinoquinolinas | |
| ECSP088360A (es) | Métodos para preparar derivados de ácido glutámico | |
| NL2002357A1 (nl) | Methods for improving the yield of cucumber plants. | |
| EA200702428A1 (ru) | Способы получения 4-бифенилилазетидин-2-онов |